The first was TNFRSF17, which was known to encode the B-cell maturation antigen and was associated with the pathogenesis and treatment of multiple myeloma and colon cancer (Shah et al., 2020; Song et al., 2022). This evidence concerns the gene TNFRSF17 and plasma cell myeloma.